Executive leadership at CDT Equity.
Board of directors at CDT Equity.
Research analysts covering CDT Equity.
Recent press releases and 8-K filings for CDT.
CDT Equity Inc. Enters into $25 Million Equity Line of Credit Facility
CDT
- CDT Equity Inc. entered into a directed stock purchase agreement on January 16, 2026, establishing an equity line of credit (ELOC) facility with an institutional investor.
- Under the ELOC, the Company has the right to sell up to $25 million of its common stock to the investor over a period of up to 36 months.
- The purchase price for shares will be 97% of the lowest volume-weighted average price (VWAP) over ten trading days, with the percentage adjusting to 95% or 94% if the VWAP falls below certain thresholds.
- The investor is not obligated to purchase shares if the VWAP is less than $1.35 (Floor Price) or if their beneficial ownership would exceed 9.99% of the Company's voting power.
- As consideration for the commitment, CDT Equity Inc. will issue 204,031 shares of Common Stock to the Purchaser.
Jan 22, 2026, 9:15 PM
CDT Equity Engages NJS Foresight Bio-Advisory for Solid-Form Out-Licensing Strategy
CDT
New Projects/Investments
Strategic Partnerships
- CDT Equity Inc. has engaged NJS Foresight Bio-Advisory, LLC to identify, source, and support the execution of out-licensing opportunities for selected assets within its solid-form patent portfolio.
- The engagement is intended to expand CDT's commercial reach and accelerate potential licensing and royalty-based transactions.
- NJS Foresight Bio-Advisory, LLC brings over 20 years of out-licensing experience and has completed numerous successful licensing agreements in the biotechnology and pharmaceutical sectors.
- CDT's solid-form patents, including cocrystals and salts, offer enhanced physicochemical properties and up to twenty years of patent protection, which can help partners extend product lifecycles.
- CDT believes current industry trends, such as responses to patent expirations and strategic consolidation, create a constructive environment for solid-form innovation and out-licensing.
Jan 2, 2026, 1:30 PM
CDT Equity Inc. Announces Reverse Stock Split
CDT
Proxy Vote Outcomes
Delisting/Listing Issues
- CDT Equity Inc. announced a 1-for-8 reverse stock split of its common stock, which will become effective on October 10, 2025, at 5:00 p.m. Eastern Time.
- The company's common stock is expected to begin trading on a reverse stock split-adjusted basis on The Nasdaq Capital Market on October 13, 2025, under the existing ticker symbol "CDT".
- Following the split, the number of outstanding common stock shares will be reduced to approximately 1,352,448, and a new CUSIP number of 20678X403 will be assigned.
- No fractional shares will be issued; stockholders who would otherwise be entitled to a fractional share will receive a proportional cash payment.
Oct 9, 2025, 12:15 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more